New Search

Advanced search
Export article

Human medicines European public assessment report (EPAR): Zalmoxis, allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2), Hematopoietic Stem Cell Transplantation,Graft vs Host Disease, Date of authorisation: 18/08/2016, Revision: 1, Status: Withdrawn

Case Medical Research
Published: 14 February 2020
Case Medical Research ; doi:10.31525/cmr-29603fe

Share this article

Click here to see the statistics on "Case Medical Research" .